Mitochondrial Diseases and Cardiomyopathies

Can J Cardiol. 2015 Nov;31(11):1360-76. doi: 10.1016/j.cjca.2015.08.017. Epub 2015 Aug 28.


Mitochondrial cardiomyopathies are clinically and genetically heterogeneous. An integrative approach encompassing clinical, biochemical, and molecular investigations is required to reach a specific diagnosis. In this review we summarize the clinical and genetic aspects of mitochondrial disorders associated with cardiomyopathy, including disorders of oxidative phosphorylation. It also describes groups of disorders that, although not usually classified as mitochondrial disorders, stem from defects in mitochondrial function (eg, disorders of β-oxidation and the carnitine cycle), are associated with secondary mitochondrial impairment (eg, organic acidurias), and are important diagnostically because they are treatable. Current biochemical and molecular techniques for the diagnosis of mitochondrial cardiomyopathies are described, and a diagnostic algorithm is proposed, to help clinicians in their approach to cardiomyopathies in the context of mitochondrial diseases.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism*
  • Cardiomyopathies* / etiology
  • Cardiomyopathies* / genetics
  • Cardiomyopathies* / metabolism
  • Humans
  • Mitochondria, Heart / metabolism*
  • Mitochondrial Diseases* / complications
  • Mitochondrial Diseases* / genetics
  • Mitochondrial Diseases* / metabolism


  • Biomarkers